Glucagon (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Glucagon drug offered from Fresenius Kabi USA, LLC. This Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Glucagon |
| SUBSTANCE NAME: | GLUCAGON HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-05-08 |
| END MARKETING DATE: | 0000-00-00 |
Glucagon HUMAN PRESCRIPTION DRUG Details:
| Item Description | Glucagon from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2015-05-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-596_59c44daa-d27d-4c54-8919-d37d5d879a70 |
| PRODUCT NDC: | 63323-596 |
| APPLICATION NUMBER: | NDA201849 |
Other GLUCAGON HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
